These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Renal effects of angiotensin converting enzyme inhibitors in hypertension. Bauer JH; Reams GP Am J Med; 1986 Oct; 81(4C):19-27. PubMed ID: 3022581 [TBL] [Abstract][Full Text] [Related]
6. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274 [No Abstract] [Full Text] [Related]
7. Treatment of hypertension with angiotensin converting enzyme inhibitors. Johnston CI; McGrath BP; Matthews PG; Jackson B Clin Exp Pharmacol Physiol Suppl; 1982; 7():135-44. PubMed ID: 6183036 [No Abstract] [Full Text] [Related]
8. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists? Bauer JH; Reams GP J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071 [TBL] [Abstract][Full Text] [Related]
9. [The clinical use of angiotensin converting enzyme inhibitors]. Fyhrquist F Duodecim; 1986; 102(22):1709-16. PubMed ID: 3026771 [No Abstract] [Full Text] [Related]
10. [Inhibition of the renin-angiotensin system in treating arterial hypertension]. Fagard R; Leuven KU; Staessen J; Amery A Ter Arkh; 1982; 54(11):68-70. PubMed ID: 6186041 [No Abstract] [Full Text] [Related]
11. Angiotensin converting enzyme inhibition in renovascular hypertension: frequency of reversible renal failure. Jackson B; Matthews PG; McGrath BP; Johnston CI Lancet; 1984 Jan; 1(8370):225-6. PubMed ID: 6198567 [No Abstract] [Full Text] [Related]
12. [Drug information. New principle in the treatment of elevated blood pressure]. Dahlerup J Sygeplejersken; 1985 Jul; 85(27):16-7. PubMed ID: 3000014 [No Abstract] [Full Text] [Related]
13. Angiotensin converting enzyme inhibition: a new therapeutic modality. Gavras H; Charocopos F; Brunner H; Gavras I Bull N Y Acad Med; 1981 May; 57(4):304-10. PubMed ID: 6164426 [No Abstract] [Full Text] [Related]
14. Rationale for the choice of antihypertensive agents. Muiesan G J Clin Hypertens; 1986 Jun; 2(2):189-94. PubMed ID: 2876062 [No Abstract] [Full Text] [Related]
15. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat. Ploth DW; Rudulph J; LaGrange R; Navar LG J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932 [TBL] [Abstract][Full Text] [Related]
16. ACE inhibition and the kidney: diagnostic and therapeutic implications. Raine AE J Hum Hypertens; 1990 Oct; 4 Suppl 4():57-61; discussion 61-2. PubMed ID: 2283655 [No Abstract] [Full Text] [Related]
17. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide. Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714 [TBL] [Abstract][Full Text] [Related]
18. [Some advances in angiotensin converting enzyme inhibitors]. Jia L Sheng Li Ke Xue Jin Zhan; 1985 Jul; 16(3):229-34. PubMed ID: 3003897 [No Abstract] [Full Text] [Related]
19. [Use of specific angiotensin inhibitors in the diagnosis and treatment of arterial hypertension]. Novikova LS; Arabidze GG Ter Arkh; 1979; 51(5):99-108. PubMed ID: 222004 [No Abstract] [Full Text] [Related]
20. [Hypertension treatment 1985: significance of calcium antagonists and angiotensin-converting enzyme inhibitors]. Weidmann P Ther Umsch; 1985 Aug; 42(8):528-39. PubMed ID: 2996166 [No Abstract] [Full Text] [Related] [Next] [New Search]